GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Kwality Pharmaceuticals Ltd

Kwality Pharmaceuticals Appoints New Statutory Auditors

MANAGEMENT ● No Immediate Change LOW RISK
📅 Filed on BSE: 12 Nov 2026, 01:07 PM IST  ·  BSE ID: ce69f5e8-d360-4eda-abf0-46facf0124d4
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's main auditors resigned, and the board accepted their decision without issues.
🤖 AI Summary
  • Kwality Pharmaceuticals accepted auditor resignation on November 12, 2026.
  • M/s. Vijay Mehra & Co. stepped down as statutory auditors.
  • No material concerns raised by the resigning auditor.
  • Board meeting also approved unaudited financial results.
🏢 How This Affects the Company
⚙️
Operational Impact
The company will need to appoint new statutory auditors to conduct financial audits.
⚠️
Risk Impact
Ensuring a smooth transition to new auditors is crucial for maintaining audit integrity and regulatory compliance.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders regarding this auditor appointment.
👤
Who Is Affected
All shareholders are indirectly affected by the change in audit firm overseeing financial reporting.
🔍
Management Signal
The board is managing administrative changes efficiently by accepting auditor resignations promptly.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Appointment of new statutory auditors.
Completion of the next audit cycle.
FY27 financial results announcement.
LOW RISK Resignation is without auditor concerns, indicating no immediate governance issues.
💡 Investor Takeaway
Kwality Pharmaceuticals' statutory auditors, M/s. Vijay Mehra & Co., resigned effective November 12, 2026. No management concerns were noted by the resigning firm.
❓ Frequently Asked Questions
Who resigned as statutory auditor of Kwality Pharmaceuticals?
M/s. Vijay Mehra & Co. resigned as the statutory auditors of Kwality Pharmaceuticals Limited, effective November 12, 2026.
Were there any concerns raised by the resigning auditors of Kwality Pharmaceuticals?
No, the filing states there were neither concerns raised by the resigning auditor with respect to the management of the Company nor any material reasons for the resignation.
What other matters were approved by Kwality Pharmaceuticals' Board on November 12, 2026?
The Board of Directors of Kwality Pharmaceuticals Limited also considered and approved the Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.